New drug KQB198 takes on advanced blood cancers in early trial
Disease control
Ongoing
This early-phase study tests a new drug called KQB198, alone or with other cancer drugs, in adults with advanced blood cancers (like certain leukemias). The main goals are to find a safe dose and see if it shrinks tumors. About 13 participants will take the drug daily and have fr…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC